Meeting report VLPNPV: Session 5: Plant based technology.

Area of Science:

• Biotechnology
• Vaccinology
• Nanotechnology

Background:

• The 2014 Virus-Like Particle and Nanoparticle Production and Purification Conference highlighted advancements in VLP and nanoparticle technology.
• Plant-based production systems are gaining traction for VLP manufacturing due to economic and safety advantages over traditional methods.

Framework:

• Focus on plant-based platforms for VLP vaccine development.
• Exploration of VLP production, purification, and delivery strategies.

Implementation:

• Demonstration of complex VLPs with precisely controlled protein expression levels.
• Development of a prime-boost HIV vaccination strategy utilizing plant-made VLPs and viral vectors.
• Characterization of plant viral nanoparticles for diverse applications.

Implications:

• Plant-based VLPs offer a scalable and cost-effective alternative for vaccine production.
• Plant viral nanoparticles show potential for cancer vaccines, targeted drug delivery, and advanced bioimaging.
• Interdisciplinary collaboration is key to advancing VLP and nanoparticle technology.